The pro‐inflammatory activity of TNF has been most convincingly shown by the positive results from agents that block TNF action in the treatment of a range of inflammatory conditions, including rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, and psoriasis.3 Here, TNF is linked to ankylosing spondylitis.